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Sunmary Neurofilaments (NFs) are specific intermediate filaments to neural cells. Mammalian NFs are
protein triplets composed of three major subunits with respective molecular weights of approximately 70, 150
and 200 kD. Using an immunohistochemical method, 13 carcinoid tumours from different sites were examined
for the presence of these three subunits by means of monospecific antisera. All tumours contained cells that
were positive for the 70 Kd subunit; nine cases contained cells immunoreactive for the 150 Kd subunit and
only three of them for the 200 kD subunit. The results indicate that the 70 kD subunit is a good overall
marker of carcinoid tumours. The 150 and 200 kD subunits are more likely to be absent in carcinoids, both
typical and atypical.
Intermediate filaments (IFs) are ubiquitous cytoskeletal; pro-
teins found in mammalian cells. Five classes of IFs can be
identified and each class is restricted to certain cell types
(Osborn & Weber, 1986; Steiner & Parry, 1985). The immuno-
histochemical demonstration of IF proteins in tumour cells is
widely recognised as an index of cellular differentiation and
this approach is therefore extensively used in the histologic
diagnosis of human tumours (Battifora, 1988; Parentes &
Rubenstein, 1987; Puts et al., 1986). Coexpression of at least
two different classes of IFs may be seen in some types of
malignancy, notably among lung tumours (Blobel et al.,
1985; Gatter et al., 1986; Lehto et al., 1985; Ramaekers et al.,
1987).
Neurofilaments (NFs) are specific intermediate filaments of
neurons of the central and peripheral nervous systems. Mam-
malian NFs are protein triplets composed of three major
subunits with respective molecular weights of approximately
70, 150 and 200 kD (Robinson & Anderson, 1988;
Schalaepfer, 1987). There are some reports of the clinical
application of immunohistochemical detection of NFs to
human neuroendocrine tumours (Lehto et al., 1983; Merot et
al., 1986; Miettinen et al., 1985; Moll et al., 1986). However
emphasis should be placed on the fact that this class of IF
consists of three subunits and in most of the studies, in the
field of tumour pathology, monospecific antibodies corre-
sponding to each of three subunits have not been used.
The present study was undertaken to investigate the
immunohistochemical reactivities to neurofilament triplet
proteins (NF.70, NF-150 and NF-200) of carcinoid tumours
and to determine whether a differential expression could be
demonstrated.
Materials and methods
A total of 13 patients with carcinoid tumours was studied.
The clinical data for these patients are summarised in Table
I. Surgically removed samples of the tumours were fixed in
10% buffered formalin, embedded in paraffin in the routine
manner and sectioned for immunohistochemical study.
Preparation ofantisera
Antisera to the individual NF-polypeptides were raised in
New Zealand white rabbits, approximately 1 kg in weight.
Purification of neurofilament triplet proteins: NF-70, NF-150
and NF-200, was achieved from pig brain by a modification
of the method of Shelanski et al. (1973). Aliquots of NF
fraction were subjected to preparative sodium dodecylsulfate
(SDS)-polyacrylamide gel electrophoresis (7'5% polyacryl-
amide, Tris-glycine buffer system) (Laemmli, 1970). After
brief staining with Coomassie Blue and destaining, the por-
tions of the gel slab containing NF-70, NF-150 and NF-200
were excised. The proteins were eluted from the gel pieces
into 90% formic acid and then dialysed against deionised
water.
The precipitated protein suspensions were emulsified with
complete Freund adjuvant and administered subcutaneously
to rabbits. Each animal received three doses of approxi-
mately 300 ugr protein each, given 3 weeks apart, and serum
was collected 7, 10 and 14 days after the second and third
injections.
Immunoblotting
After the completion of electrophoresis, one set of lanes was
stained in Coomassie Blue while the other sets were each
transferred electrophoretically to nitrocellulose (Towbin et
al., 1979). Transfer was carried out for 18 h. The nitrocel-
lulose sheets were incubated sequentially as follows: 5%
bovine serum albumin (BSA), 30 min, primary antiserum
diluted 1/50-1/250, 15min, wash buffer (WB), 3-10min,
swine anti-rabbit IgG (Dako, Santa Barbara, CA), 1/50,
15min, WB, 3-10min, rabbit peroxidase/antiperoxidase
(Dako), 1/50, 15 min, WB, 3-10 min. Bands were developed
with diaminobenzidine, 0.5 mgr ml-' in 0.015% hydrogen
peroxide. WB consisted of0.15 M NaCl, 0.05 M Tris, Nonidet
P-40, 0.1% BSA and 0.02% sodium azide, pH 8.0. All dilu-
tions were made in WB containing 1% BSA.
Immunohistochemistry
Immunohistochemical staining for the triplet proteins was
performed according to Sternberger (1986). The paraffin sec-
tions from formalin-fixed material were used for staining
after a careful deparaffinisation, through xylene and graded
alcohols. Endogenous peroxidase was then inactivated by
immersion in 0.3% hydrogen peroxide in phosphate buffer
(phosphate-buffered saline 0.2 M, pH 7.4 PBS) for 30 min at
room temperature followed by the primary antiserum. The
primary antisera, all raised in rabbits, were applied at
predetermined optimal dilutions (1/150 for NF-70, 1/200 for
NF-150 and 1/100 for NF-200) in PBS for overnight at 4°C
in a damp chamber. After washing (0.5 M Tris buffer,
pH 7.4), the second layer antibody (swine anti-rabbit Ig G,
Dako, Santa Barbara, CA) 1/50 was applied for 30min at
room temperature. Finally after washing, rabbit peroxidase-
antiperoxidase (PAP) (Dako) diluted 1/50 was placed on the
sections. The specific sites of immunoreaction were developed
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in a solution of PBS containing 0.0006% hydrogen peroxide
and 0.025% diaminobenzidine (Sigma, St Louis, MO, USA).
The sections were then dehydrated through graded alcohols
and xylene and mounted in a permanent medium (DPx).
Negative controls that were carried out comprised dilution
of the primary antiserum and their substitution with non-
immune serum. Moreover, preabsorption of the primary
antibody with the purified antigen resulted in loss of
immunostaining. They were used at concentrations of
100-250ugrml-' of antiserum, incubated for 2h at 25°C
and centrifugated at 3,000g for 15 min; the resultant super-
natant was incubated in the usual manner for the primary
antisera.
As positive controls, cultured neurones of cerebral hemi-
spheres from rat embryos and sections from formalin-fixed
rat brain were used. Before incubation with the primary
antisera, in a humid chamber for 2h, cells on coverslips
were: (1) washed with PBS for 5 min, (2) fixed with 10%
paraformaldehyde in PBS (5 min), (3) washed twice with PBS
for 10min each. Sections from rat brain were processed as
tumour sections.
Results
Light microscopic examination revealed well-circumscribed
tumours with small, uniform cells frequently grouped in a
trabecular pattern, but in cases 7 and 8 spindle-shaped cells
were observed. Three cases (7, 8 and 12) showed focal nec-
rosis as well as mitoses.
Figure 1 shows the results of the immunoblotting method
for checking the specificities and characterisation of the
antisera. Our antisera to the 70kD, 150kD and 200kD
subunits reacted to each antigen (subunit) alone. The con-
trols, in which normal rabbit serum (non-immune serumn) or
antisera preabsorbed with the corresponding antigens in
excess were used, did not show immunoreactivity. In positive
controls, neurones showed a strong staining and all
antibodies reacted to neuronal perikarya and processes
(Figures 2 and 3).
The results of the study on the localisation of
neurofilament triplet proteins in 13 carcinoid tumours are
presented in Table I. The only normal structures labelled
200 kD
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Figure 1 The specificities of antisera to the 70 kD, 150 kD and
200 kD subunits were examined by the immonoblotting method.
Lane A shows SDS gel (7.5% polyacrylamide) of pig
neurofilaments stained with Coomassie Blue. Lanes B, C and D
are the results of transfer of Lane A to the nitrocellulose sheets.
Lanes B, C and D shows the results of staining by peroxidase-
antiperoxidase (PAP) complex using anti-70 kD antiserum, anti-
150 kD antiserum and anti-200 kD antiserum respectively. It is
noted that each antiserum reacts to each antigen (subunit) alone.
Figure 2 Photomicrograph of section from rat cerebral hemi-
spheres. Immunohistochemical staining for the 70 kD subunit
(with counterstain); a neuron clearly positive is shown. Immuno-
staining for the 150 and 200 kD subunits showed similar results
(original magnification: x 1250).
Figure 3 Immunohistochemical staining of primary culture from
embryonic rat cerebral hemispheres with specific 70 kD
antiserum. The cells were cultured for 12 days. Note that only the
neurones are immunoreactive (original magnification: x 1250).
Table I
Neurofilament
triplet proteins
Case Age Sex Sites 70kD 150kD 200kD
1 42 M Appendix + + +
2 50 F Appendix + +
3 32 M Appendix + +
4 40 F Intrabronchial + + +
5 41 M Intrabronchial + +
6 55 F Intrabronchial +
7 62 F Intrabronchial +
8 47 M Peripheral lung +
9 75 F Ileum + +
10 70 M Ileum + +
11 71 F Gallbladder + + +
12 58 M Mediastinum +
13 64 F Breast + +
with anti-NF protein antibodies were nerve axons and gang-
lion cells; these were used as the positive controls. In order to
investigate the differential expression of neurofilament
subunits, we assessed immunoreactivity in several serial sec-
tions. All carcinoids showed positive cells when stained with
antibody to the 70 kD subunits; nine tumours contained cells
immunoreactive for the 150 kD subunit and only three of
them for the 200 kD subunit. In most cases, immunoreac-
tivity was juxtanuclear focal. Staining of the sections showed
that the antibodies to the 150 kD and 200 kD subunits do
not react with all cells that positively stained with antibody
to the 70 kD subunit. Furthermore, in each case, the number
ofpositive cells varied depending on the antibody used. SlicesNEUROFILAMENT TRIPLET PROTEINS IN TUMOURS 717
stained with antibody to the 70 kD subunit showed the
largest number of positive cells; there were fewer cells reac-
ting with antibody to the 150 kD subunit and even fewer cells
reacting with antibody to the 200 kD subunit. Figures 4-6
illustrate these findings.
Figure 4 Immunohistochemical staining of a carcinoid tumour
with monospecific antibodies to neurofilament triplet proteins.
(PAP method). Immunostaining for the 70 kD subunit with
counterstain (original magnification: x 1,000).
Figure 5 Immunohistochemical staining of a carcinoid tumour
with monospecific antibodies to neurofilament triplet proteins.
(PAP method). Immunostaining for the 150 kD subunit with
counterstain (original magnification: x 1,000). Note that a
greater number of immunoreactive cells is found with antibody to
the 70 kD subunit.
Figure Immunohistochemical staining of a carcinoid tumour
antibody
to the 200 kD subunit (PAP method). Note the
scarcity immunoreactive cells (original magnification: x 1,000).
At times, the staining reactions were weaker with antibody
to the 200 kD subunit. It was possible to detect tumour cells
in which the 70 kD subunit existed by itself, but tumour cells
in which the 150 or 200 kD subunits existed alone could not
be detected. Positive cells for both 150 and 200 kD subunits
were not demonstrated in all atypical carcinoids as well as in
one of the 10 typical tumours.
Discussion
In this study, we analysed immunohistochemically the differ-
ential expression of neurofilament triplet proteins (NF-70,
NF-150 and NF-200) in 13 carcinoid tumours from different
sites. Three tumours were classified as atypical carcinoids,
two bronchopulmonary and one in the mediastinum.
Neurofilaments (NFs) are specific neural markers and have
been found in some neuroendocrine neoplasms: oat cell car-
cinoma of the lung (Broers et al., 1985; Lehto et al., 1983),
islet cell tumours and cutaneous neuroendocrine carcinoma
(Domagala et al., 1987; Merot et al., 1986). In relation to
carcinoids, our results are in agreement with early reports
(Altmannsberger et al., 1984; Lehto et al., 1984; Lehto et al.,
1985). In contrast, some authors (Broers et al., 1985; Tro-
janowski et al., 1984) considered carcinoid tumours to be
negative for neurofilament antigens; Blobel et al. (1985)
found weak immunoreactivity for the 70 kD subunit in two
of four bronchopulmonary carcinoids examined by immuno-
fluorescence microscopy. Some factors such as tissue prepara-
tion (e.g., interval from excision to fixation, duration of
fixation, embedding methods, immunohistochemical proce-
dure) may have contributed to the divergent results. Also it is
possible that the anti-NF monoclonal antibodies employed in
some studies do not recognise the epitopes of NFs present in
the tumours of putative neuronal origin. Christen et al.
(1987), using monoclonal antibodies for phosphorylated and
non-phosphorylated isoforms of the high-molecular-weight
neurofilament subunit, detected both NF-proteins in typical
bronchial carcinoids but not in atypical carcinoids. We found
neither immunoreactive cells for the 200 kD subunit in
tumours with atypical histological characteristics. The
presence of NF-immunoreactivity in juxtanuclear aggregates
was striking; masses of NFs have been described in a variety
of pathologic conditions and they may reflect abnormalities
in intermediate filament metabolism (Trojanowski, 1987).
The histogenesis of the dispersed neuroendocrine system
remains uncertain (Gould et al., 1983). Many neuroendocrine
carcinomas express more than one class of intermediate
filaments, often coexpress cytokeratin and NFs (Gatter et al.,
1986; Lehto et al., 1985; Merot et al., 1986; Miettinen et al.,
1985; Ramaekers et al., 1987) and this coexpression may be
related to a special histogenesis. Tumours with an established
neural crest derivation display divergence in their inter-
mediate filament expression, probably reflecting the early
segregation of neural crest cells before migration and their
different susceptibility to environmental influences (Ziller et
al., 1983). In bronchopulmonary carcinoids, Kulchitsky cells
are considered to be candidate precursor cells for these
tumours and it has reported the presence of NF-subunits in
Kulchitsky cells of human bronchial epitheliam (Torika et
al., 1986); it will be important to learn whether these cells
express keratin filament proteins. Some authors (Fischer et
al., 1989; Van Muijen et al., 1984) have detected immuno-
reactive cells for NF-proteins in circumscribed areas of some
squamous cell carcinomas, but it seems unrelated to the
morphologic differentiation of the neoplasms.
The present study is the first in which the differential
expression of neurofilament triplet proteins was evaluated in
carcinoids. Our results revealed that the 70 kD subunit is a
good indicator of this tumour both from the aspect of the
number of patients with positive findings and the number of
immunoreactive cells; the 150 and 200 kD subunits are more
likely to be absent in carcinoids, both typical and atypical.
However only 13 cases have been included in this series and
more definitive conclusions must await further studies.718 R. ASTARLOA et al.
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